Intuitive Surgical (ISRG) Change in Accured Expenses (2009 - 2026)
Intuitive Surgical (ISRG) posted Change in Accured Expenses of $55.0 million for Q2 2026, up 119.32% on a QoQ basis from -$284.7 million in Q1 2026, and down 50.5% year-over-year from $111.1 million in Q2 2025.
Analysis
Intuitive Surgical (ISRG) Change in Accured Expenses (2009 - 2026) Analysis & Trends
Intuitive Surgical has reported Change in Accured Expenses for 18 years, with the latest figure at $55.0 million in Q2 2026.
- On a quarterly basis, Change in Accured Expenses fell 50.5% year-over-year to $55.0 million in Q2 2026; TTM through Jun 2026 was -$2.1 million, a 101.94% decrease from a year earlier, with the FY2025 full-year figure at $112.7 million, up 4.06% from the prior year.
- Change in Accured Expenses was $55.0 million for Q2 2026 at Intuitive Surgical, up from -$284.7 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $227.1 million in Q3 2023, with the low at -$284.7 million in Q1 2026.
- Average Change in Accured Expenses over 5 years is $8.2 million, with a median of $57.5 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses surged 731.88% in 2022, then plunged 328.45% in 2023.
- Over 5 years, Change in Accured Expenses stood at $60.1 million in 2022, then plunged by 328.45% to -$137.3 million in 2023, then jumped by 221.78% to $167.2 million in 2024, then increased by 15.37% to $192.9 million in 2025, then slumped by 71.49% to $55.0 million in 2026.
- The last three Change in Accured Expenses figures came in at $55.0 million (Q2 2026), -$284.7 million (Q1 2026), and $192.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 55.00 Mn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | -531.00 Mn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 298.00 Mn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 234.00 Mn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 123.70 Mn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | -74.00 Mn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 112.90 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn | 92.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.00 Mn |
| Mar 31, 2026 | -284.70 Mn |
| Dec 31, 2025 | 192.90 Mn |
| Sep 30, 2025 | 34.70 Mn |
| Jun 30, 2025 | 111.10 Mn |
| Mar 31, 2025 | -226.00 Mn |
| Dec 31, 2024 | 167.20 Mn |
| Sep 30, 2024 | 56.20 Mn |
| Jun 30, 2024 | 156.10 Mn |
| Mar 31, 2024 | -271.20 Mn |
| Dec 31, 2023 | -137.30 Mn |
| Sep 30, 2023 | 227.10 Mn |
| Jun 30, 2023 | 85.60 Mn |
| Mar 31, 2023 | -140.60 Mn |
| Dec 31, 2022 | 60.10 Mn |
| Sep 30, 2022 | 133.10 Mn |
| Jun 30, 2022 | 58.80 Mn |
| Mar 31, 2022 | -130.30 Mn |
| Dec 31, 2021 | 80.10 Mn |
| Sep 30, 2021 | 16.00 Mn |